The market for stem cell supplements just keeps growing. The products are expensive and have little data to back up their marketing. With this post, I’m calling on the FDA to do more here. Let’s go through the risks here and why I believe that drug classifications are appropriate in some cases. Some of the […]
FDA should act on stem cell supplements as some are actually drugs Read More »
Longevity is still the big thing both these days. There’s some solid science here. There are also tons of people just trying to make as much money as possible on this. Maybe it’s not surprising that there’s a sea of hype here. Perhaps one could make a graph with the average age of populations over
After years of legal battles, the FDA has secured what appears to be a decisive federal court victory in its effort to regulate one type of stem cell clinic. This ruling has implications for other clinics too. The U.S. Supreme Court just declined to review a key case that the FDA had won on appeal
FDA secures major win as SCOTUS lets stem cell clinic ruling stand Read More »
Many researchers around the world are trying to make human eggs outside the body. The main point of this lab effort to make human oocytes seems to be to assist with infertility. However, the broader technology of in vitro gametogenesis or IVG (which in theory could make eggs or sperm) could also be used to
How high is stem cell therapy cost now? Is it higher or lower than in the past? Every few years, I run polls asking readers of The Niche who have gotten stem cell therapies to provide data. I ask them how much they paid per therapy and how many injections they got. The reason for
Polling on stem cell therapy cost: what did you pay & how many did you get? Read More »
Is there such a thing as avian embryonic stem cells, meaning bird ESCs? Yes, you can make ESCs and induced pluripotent stem cells (iPSCs) from many species of vertebrates including birds. Some have been much harder to derive than others though. Bird ESCs In fact, for some species, certain tricks or additional materials are needed.
What’s ReCELLebrate? Sometimes I end up on mailing lists from companies selling biologics for which I don’t see clear FDA approval. Not all biologics need drug-level approval from the agency, but many do. All exosomes appear to require FDA approval before use. ReCELLebrate is a regenerative firm that just sent me two marketing emails. The
ReCELLebrate, IV exosome booth today, & leader Dr. Jeffrey Gross Read More »
Lately, we’ve been hearing more about something called “in vivo reprogramming.” It comes up frequently in the longevity space. Today’s post explains this cutting-edge area of research and its hoped-for, potential clinical applications. What’s most intriguing about vivo reprogramming is that it could potentially regenerate or heal tissues from the inside. It’s both exciting and
What is in vivo reprogramming, its potential pros & cons? Read More »
The conservative Wall Street Journal continues to go after FDA CBER Director Vinay Prasad. WSJ still doesn’t like CBER Director Vinay Prasad What’s going on? Here’s a new piece from the paper’s editorial board: Dr. Prasad, the FDA’s Grim Reaper. That’s a strong headline. The piece is also critical of RFK Jr. Earlier Prasad temporarily
Weekly reads: WSJ vs. Prasad, MUSE cells, Lyme disease, longevity signal vs. noise Read More »
Dental stem cell banking is a small but rapidly emerging trend in the regenerative space. Marketing about potential uses of these tooth cells often has gotten way ahead of the science. Some clinics and cell banking firms are already suggesting dental stem cell banking as a source of cells to treat specific health conditions yet
Dental stem cell banking makes ‘outrageous’ claims in UK, practice is widespread in US Read More »